i have only just found out, great news, page-10

Terumo have chosen OMI for their 1ml upto 10ml retractable syringes. As you say the clip-on device is a different product, but I do believe the 2 products will compete with each other to some degree.

Terumo, have expressed an interest in purchasing 200 million needles from EMS, not the clip-on device. I am not sure as to the extent of Termuo's manufacturing of products, I believe they be trying to source the needles for other manufacturers globally. This is all good, although it may eat into EMS's margins a little.

The OMI product is being manufactured by "China Medical Group". I am not sure were these guys source their needles from, but in order to utilize the 1 Billion a year capacity using PAP, EMS needs to be supplying these people and many other manufacturers with needles.

I do believe that due to the cost savings with PAP, EMS will be able to gain a very high percentage of the world-wide market for needles, but this is going to take quite a few years still.

In the meantime, EMS will be profitable due to their other products and the aquisition of MIA. At the same time the expence of their expansion plans over the next few years will keep this profit small and I would not expect any form of dividend for quite a while ( at a guess 2 years minimum).

I have believed EMS are a great company for quite a while now, and they will reward their shareholders. I am just concerned as to the timeframe thus no longer hold the stock, though I assure you I will be back buying again when either the time, or the price is right for me.